Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

Blood Adv. 2024 May 14;8(9):2130-2132. doi: 10.1182/bloodadvances.2023011433.

Mario Andrés Sánchez-Salinas^{1

2}, Marta Miarons^{3

4}, Iñaki F Troconiz⁵, Víctor Navarro⁶, Javier Varela³, Gloria Iacoboni^{1

2}, Pere Barba^{1

2}

¹ Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
² Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
³ Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
⁴ Pharmacy Department, Consorci Hospitalari de Vic, Barcelona, Spain.
⁵ Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
⁶ Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

No abstract available

MeSH terms